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Methods. Retrospective cohort study of hospitalized adults with a positive culture for MA at Jackson Memorial Hospital (1,550-beds) and the University of Miami Hospital (550-beds) Miami, FL (January 1, 2011 to January 31, 2014). Demographics, comorbidities, source of infection, antimicrobial susceptibilities and clinical outcomes were analyzed. Treatment failure was defined as death and/or infection relapse within 4 weeks of treatment. Mortality was defined as death related to MA during hospital stay. Data were analyzed using SPSS version 16.
Results. 68 patients were analyzed. Mean age 51.16 ± 19.46 years, 35 (51.5%) males, 28 (41.2%) Hispanics, 7 (10.3%) end-stage renal disease, 16(21.9%) were on immunosuppressive therapy (IT). Organisms were isolated: 40 (58.8%) respiratory sources, 14 (20.6%) blood, 11 (16.2%) skin and wound cultures, 5 (7.4%) peritoneal catheter associated infections, 2 (2.9%) bone. Antimicrobial susceptibility reports were available for 26 (35.4%) of the patients. Of those: 26 (100%) were susceptible (S) to amikacin, 19 (73.1%) clarithromycin, 10 (38.5%) tigecycline, 8 (30.7%) linezolid, 4(15.4%) cefoxitin. Only 2 (7.7%) were S to imipenem, fluoroquinolones (FQs) and tobramycin, 14 (53.8%) were intermediate to imipenem and 17 (65.4%) to cefoxitin. Few organisms were tested for susceptibilities to clofazimine 5 (100%) and azithromycin 4 (80%). 24 (35.3%) patients failed treatment; of those, 12 (14.7%) died. Risk factors significantly associated with treatment failure were acute kidney injury ( p =0.001), dialysis ( p = 0.002), solid organ transplant ( p = 0.03), second site of infection ( p = 0.04), IT ( p = 0.02) and presence of prosthetic device ( p = 0.04).
Conclusion. There is a high prevalence of MA in Miami with an in-hospital mortality rate of 14.7%. The most frequent source of infections was respiratory (57.4%). We found a high proportion of FQs resistance. Clarithromycin and amikacin were the most likely to be susceptible in-vitro. Immunosuppression and renal disease were significantly associated with treatment failure.
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